about
Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation.Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth.Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice.PI3K/mTOR signaling regulates prostatic branching morphogenesisSecreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome.X-ray-visible microcapsules containing mesenchymal stem cells improve hind limb perfusion in a rabbit model of peripheral arterial disease.Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer.Mycobacterium abscessus pneumonia in an Atlantic bottlenose dolphin (Tursiops truncatus).Intraperitoneal delivery of paclitaxel by poly(ether-anhydride) microspheres effectively suppresses tumor growth in a murine metastatic ovarian cancer modelCharacterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy.Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition.Severity of post-ERCP pancreatitis directly proportional to the invasiveness of endoscopic intervention: a pilot study in a canine model.IDENTIFICATION OF MYCOBACTERIUM GENAVENSE IN A DIANA MONKEY (CERCOPITHECUS DIANA) BY POLYMERASE CHAIN REACTION AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY.Molecular effects of genistein on male urethral development.Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancerA novel viscous dissecting gel for endoscopic submucosal dissection: a prospective survival study in a porcine modelNanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancerTargeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer
P50
Q30844270-F265BCDB-FE12-4D41-95D8-D821BCC6E5D5Q33763847-9903E935-A8B0-4FB3-96BD-5F8C96B047C2Q35048524-4C5AD725-03DA-4EA8-90D0-FBF2AE4906A9Q35575601-F8CA976E-1638-4830-93A6-6A23970E5E56Q36236135-88197B79-EEC1-4693-8112-5E4B0EC12764Q36842323-1A45D206-7465-4AA0-BFDF-B2100973222CQ37178620-C4E13FC5-8A6E-47A3-B930-9A0953A08156Q37243892-141D4B3F-09D1-42A5-864F-7F84BD348C00Q37640704-F05AE744-86C2-42F8-BB0E-703FC6C4C361Q38782953-5ECE90B2-3503-4D81-B4D8-86385ED8AE03Q39339148-A25A9677-0D90-4334-B8D5-00AE5CE2B5E2Q40092058-21E076F5-20E9-4383-BB59-82D199BC47BFQ40152447-E676F4CD-C1E8-4FFC-AEAD-B4D0A9150D4CQ43457477-300A0714-7FF1-40A0-8635-0DE6F325830DQ56892705-9936E131-8639-4FA1-829F-5A49A0DCACDBQ61534844-41046760-2B3B-48EB-92D2-CE77A18F7CA6Q90782647-9F31255D-05D1-4651-8F5E-79AE6743A2F1Q91254638-C6B0F540-56F2-4E3F-B862-E92C6F6EA36C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Brian W. Simons
@ast
Brian W. Simons
@en
Brian W. Simons
@es
Brian W. Simons
@nl
Brian W. Simons
@sl
type
label
Brian W. Simons
@ast
Brian W. Simons
@en
Brian W. Simons
@es
Brian W. Simons
@nl
Brian W. Simons
@sl
prefLabel
Brian W. Simons
@ast
Brian W. Simons
@en
Brian W. Simons
@es
Brian W. Simons
@nl
Brian W. Simons
@sl
P106
P1153
24448232200
P21
P31
P496
0000-0003-0644-211X